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plastic surgery and radiotherapy, and finally, new systemic
treatments (hormonal, chemotherapeutic and genetic) have
contributed to many more lives, and breasts, saved.
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Ritalin — on the bandwagon?
To the Editor: The new Ritalin-LA (long acting) was launched
at the beginning of this year at a roadshow throughout the
country. As with many new drugs it became so popular that
almost a month after the launch it was out of stock.
Unfortunately since then I have seen some very worrying
tendencies appear on the horizon. It seems that Ritalin is
increasingly being prescribed without thorough assessment.
One such example involves 4-year-old boy who was put on
Ritalin-LA 30 mg after a complaint by a nursery school teacher
that he could not sit still. Another involves a girl aged 12 years
with sudden regression in school performance and behaviour,
who was put on Ritalin-LA 20 mg, without any response. A full
evaluation revealed that she had been sexually abused.
Another worrying development is that more and more mothers
are phoning to ask for advice after their child has been put on
Ritalin and now has side-effects, with which the prescribing
doctor does not know how to deal.
Ritalin is an excellent and wonderful drug for children who
need it. However, it is my impression that the roadshow
(unintentionally!) might have given the impression to doctors
unfamiliar with the field of developmental paediatrics that the
long-acting version is now a quick fix for concentration
problems. The talk on attention deficit and the functioning of
Ritalin was excellent, but it is important to realise that attention
deficit disorder is only one block in the puzzle of
developmental paediatrics and not the puzzle itself. It is
therefore important to adopt a holistic approach in the case of
the child presenting with concentration problems. This
includes, over and above a full assessment of the main
complaint, a thorough assessment of the child’s emotional
status, social abilities, learning problems, other co-morbid
conditions that might co-exist, and extremely important, also
educational and family psychodynamics. Only when all these
factors are taken into account and fully assessed can a
treatment protocol for each child be individualised and put
into place. If we neglect our duty in this regard we are going
back to the seventies when Ritalin was dished out right, left
and centre — when stopped in those days at 12 years of age,
many children still could not read, write or socialise, and still
struggled with behaviour problems and low self-esteem.
There is also a tendency for children to get referred from
occupational or speech therapists, or even in some instances
from the teacher, with the instruction that the child be put on
Ritalin — and the doctor faithfully obeys.
Professor Johan Prinsloo once said: ‘The most important
thing for a doctor is to know when he does not know.’ I know
that this is general knowledge, but it is still important for any
medical professional to have a sound knowledge of the
functioning and side-effects of any medication that s/he uses
and to have a thorough knowledge and understanding of the
condition being treated. It is in the interests of all children with
developmental problems that they, their families and schools
can rely on correct diagnosis and continuous support. Treating
these children is not a quick prescription, it is a lifelong
commitment.
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Weak knees
To the Editor: SAMA online (27 February) reports the South
African Medical Association (SAMA)’s comments on the
pressure from the Board of Health Care Funders (BHC) to force
medical practitioners to contribute to the BHC practitioner
register. SAMA states that discussions with the BHC have been
unsatisfactory in many ways and SAMA said that it wished to
verify and clarify some aspects further.
However, SAMA then goes on to say that it recommends that
all medical practitioners concede to the request, because
‘otherwise they may not get paid’. 
This weak capitulation is not what is expected of SAMA. It
seems that SAMA has no appreciation of its powerful authority.
A directive from SAMA to all medical practitioners,
recommending that payment should be withheld, would stop
short the BHC pressure immediately and so allow all necessary
clarification.
Once a concession is made to the BHC demands, the
precedent will be set, and become irreversible. After this the
BHC will cock a snook at any attempts at further ‘verification
and clarification’.
This additional cost burden, which is of doubtful value to the
individual practitioner, will then become yet another legacy of
weak ineptitude to be inherited by our successors.
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